Novabay Pharmaceuticals Inc
ASE:NBY 9:33:32 AM EDT
| Market Cap (Intraday) | 29.36M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.72 |
| 50-Day MA | $0.73 |
| 200-Day MA | $0.81 |
Novabay Pharmaceuticals Inc Stock, ASE:NBY
2000 Powell Street, Suite 1150, Emeryville, California 94608-1866
United States of America
Phone: +1.510.899.8800
Number of Employees: 25
Description
NovaBay Pharmaceuticals, Inc. engages in development of products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.